Recently, the Development and Reform Commission of Dezhou City released the Notice on the Announcement of the List of Dezhou City Engineering Research Centres Recognised in 2022 (Dezhou Development and Reform High Technology [2022] No. 208), and Shandong Sihuan Pharmaceutical Co., Ltd, a subsidiary of Tianming Pharmaceutical Group, was recognised as the Dezhou Anti-Diabetic Drug Engineering Research Centre.

Shandong Tianming Pharmaceutical Group is a national high-tech enterprise engaged in the research and development, production and sales of new drugs and health products. The company actively implements the innovation-driven development strategy, with nearly 6,000 sq. ft. of R&D area and a R&D team of more than 100 people, and has built high-standard R&D laboratories for synthesis, fermentation, polymer and formulation, with comprehensive strength from laboratory research, pilot scale up to industrial production.

The recognition as the Engineering Research Centre of Dezhou City is another honour for the company after the National High-tech Enterprise, Shandong Provincial Specialized and New Enterprise, Shandong Science and Technology Small and Medium-sized Enterprise and Dezhou Enterprise Technology Centre. The company will continue to rely on the various research platforms, and continue to innovate and change in the areas of organisation, management, R&D innovation, talent training, and cooperation between industry, academia and research to help the rapid development of the enterprise.